Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Galasko

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Neurology|December 1, 1993
The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's diseaseJ C Morris, S Edland, C Clark, et al.
Annals of Neurology|January 1, 1995
The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's diseaseT Saitoh, Y Xia, X Chen, et al.
Neurology|December 1, 1995
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adultsM W Bondi, D P Salmon, A U Monsch, et al.
Archives of Neurology|September 1, 1994
Clinical-neuropathological correlations in Alzheimer's disease and related dementiasD Galasko, L A Hansen, R Katzman, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative StudyJ A Mackell, S H Ferris, R Mohs, et al.
Neurology|January 1, 1990
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entityL Hansen, D Salmon, D Galasko, et al.
Annals of Neurology|July 1, 1997
Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutationR Crook, R Ellis, M Shanks, et al.
Annals of Neurology|October 1, 1995
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseR Motter, C Vigo-Pelfrey, D Kholodenko, et al.
Archives of Neurology|April 1, 1996
Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profileG M Peavy, D P Salmon, V A Rice, et al.
Neurology|February 16, 2011
Global clinical dementia rating of 0.5 in MCI masks variability related to level of functionY-L Chang, M W Bondi, L K McEvoy, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Neurology|December 1, 1993
The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's diseaseJ C Morris, S Edland, C Clark, et al.
Annals of Neurology|January 1, 1995
The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's diseaseT Saitoh, Y Xia, X Chen, et al.
Neurology|December 1, 1995
Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adultsM W Bondi, D P Salmon, A U Monsch, et al.
Archives of Neurology|September 1, 1994
Clinical-neuropathological correlations in Alzheimer's disease and related dementiasD Galasko, L A Hansen, R Katzman, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative StudyJ A Mackell, S H Ferris, R Mohs, et al.
Neurology|January 1, 1990
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entityL Hansen, D Salmon, D Galasko, et al.
Annals of Neurology|July 1, 1997
Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutationR Crook, R Ellis, M Shanks, et al.
Annals of Neurology|October 1, 1995
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseR Motter, C Vigo-Pelfrey, D Kholodenko, et al.
Archives of Neurology|April 1, 1996
Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profileG M Peavy, D P Salmon, V A Rice, et al.
Neurology|February 16, 2011
Global clinical dementia rating of 0.5 in MCI masks variability related to level of functionY-L Chang, M W Bondi, L K McEvoy, et al.
Pageof 11